MedTrace Logo

Preventive Potential of Bilirubin

NCT04792996 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-03-11

No results posted yet for this study

Summary

The prevalence of mild hyperbilirubinemia, also known as Gilbert´s Syndrome, is usually defined using an unconjugated bilirubin (UCB) blood concentration above 17.1 µmol/l. The prevalence of GS is remarkably common, affecting 5-10% (depending on ethnicity and gender) of the adult population.

The aim of this project is to investigate whether there is a difference in health related marker between 60 subjects with Gilbert´s Syndrome (mild hyperbilirubinaemia) and 60 age and gender matched control subjects.

Conditions

  • Mild Hyperbilirubinaemia

Interventions

OTHER

No intervention

No intervention. case - control design.

Sponsors & Collaborators

  • Medical University of Vienna

    collaborator OTHER

  • University of Vienna

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-01
Primary Completion
2016-06-01
Completion
2016-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792996 on ClinicalTrials.gov